Jgp Global Gestao De Recursos Ltda. Neurocrine Biosciences Inc Transaction History

Jgp Global Gestao De Recursos Ltda.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$87.57 - $119.4 $248,786 - $339,215	-2,841 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$86.91 - $108.33 $6,170 - $7,691	-71 Reduced 2.44%	2,841 $272,000
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $12,981 - $18,245	-135 Reduced 4.43%	2,912 $280,000
Q1 2020 May 07, 2020	SELL	$75.11 - $113.76 $6,534 - $9,897	-87 Reduced 2.78%	3,047 $263,000
Q4 2019 Jan 24, 2020	BUY	$86.8 - $118.57 $3,211 - $4,387	37 Added 1.19%	3,134 $337,000
Q3 2019 Oct 29, 2019	BUY	$83.82 - $101.5 $13,662 - $16,544	163 Added 5.56%	3,097 $279,000
Q2 2019 Jul 19, 2019	SELL	$72.24 - $91.27 $24,850 - $31,396	-344 Reduced 10.49%	2,934 $248,000
Q1 2019 Apr 24, 2019	BUY	$69.31 - $91.53 $19,476 - $25,719	281 Added 9.38%	3,278 $289,000
Q4 2018 Jan 23, 2019	BUY	$68.32 - $124.36 $204,755 - $372,706	2,997 New	2,997 $214,000

657

101M

290K

214K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.